Download presentation
Presentation is loading. Please wait.
Published byDrusilla Williams Modified over 6 years ago
1
Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes Gilbert R. Thompson, Mary Seed, Rossi P. Naoumova, Clare Neuwirth, Shahenaz Walji, Timothy J. Aitman, James Scott, Nicolas B. Myant, Anne K. Soutar Atherosclerosis Volume 243, Issue 1, Pages (November 2015) DOI: /j.atherosclerosis Copyright © 2015 Elsevier Ireland Ltd Terms and Conditions
2
Fig. 1 Comparison of pre- and on-treatment serum total cholesterol (TC) in dead and alive FH homozygotes. The on-treatment TC in patients who were on apheresis was calculated as the mean of the pre-procedure values. Atherosclerosis , DOI: ( /j.atherosclerosis ) Copyright © 2015 Elsevier Ireland Ltd Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.